Quick Links
You are about to leave www.astellas.com and enter a third-party website. Astellas is not responsible for the content or services on the third-party website.
Would you like to continue?
Astellas is committed to providing timely and accurate information about our business, science and products. This section offers local resources for investors, journalists and media professionals. Global news and resources can be viewed here. If you are not an investor or journalist, click here.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
2024年6月3日（北京）——...
2024年5月12日母亲节到来之际，由北京市朝阳区青年志愿者协会和北京和众泽益公益发展中心发起的“为妈妈奔跑”公益健步走活动在北京市朝阳区黑
–关键性试验发现，与含铂化疗相比，enfortumab vedotin 与 pembrolizumab联合疗法显著延长了总生存期和无进展生存期– –如获批，enfortumab vedotin 与...
VYLOY在日本被批准与化疗联合治疗人体表皮生长因子受体2（HER2）阴性、CLDN18.2阳性、不可切除晚期或复发性胃癌患者...
Follow China news
